ArticleOncotarget2016

MMP-1 promoter polymorphism is associated with risk of radiation-induced lung injury in lung cancer patients treated with radiotherapy.

Bo Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.